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Srinivasan M, Choi CS, Ghoshal P, Pliss L, Pandya JD, Hill D,
Cline G, Patel MS. ␤-Cell-specific pyruvate dehydrogenase deficiency impairs glucose-stimulated insulin secretion. Am J Physiol
Endocrinol Metab 299: E910 –E917, 2010. First published September
14, 2010; doi:10.1152/ajpendo.00339.2010.—Glucose-stimulated insulin secretion (GSIS) by ␤-cells requires the generation of ATP from
oxidation of pyruvate as well as generation of coupling factors
involving three different pyruvate cycling shuttles. The roles of
several key enzymes involved in pyruvate cycling in ␤-cells have
been documented using isolated islets and ␤-cell clonal lines. To
investigate the role of the pyruvate dehydrogenase (PDH) complex
(PDC) in GSIS, a murine model of ␤-cell-specific PDH deficiency
(␤-PDHKO) was created. Pancreatic insulin content was decreased in
1-day-old ␤-PDHKO male pups and adult male mice. The plasma
insulin levels were decreased and blood glucose levels increased in
␤-PDHKO male mice from neonatal life onward. GSIS was reduced
in isolated islets from ␤-PDHKO male mice with about 50% reduction
in PDC activity. Impairment in a glucose tolerance test and in vivo
insulin secretion during hyperglycemic clamp was evident in
␤-PDHKO adults. No change in the number or size of islets was found
in pancreata from 4-wk-old ␤-PDHKO male mice. However, an
increase in the mean size of individual ␤-cells in islets of these mice
was observed. These findings show a key role of PDC in GSIS by
pyruvate oxidation. This ␤-PDHKO mouse model represents the first
mouse model in which a mitochondrial oxidative enzyme deletion by
gene knockout has been employed to demonstrate an altered GSIS by
␤-cells.
pyruvate cycling; ␤-cell hypertrophy
INSULIN SECRETION by pancreatic islet ␤-cells is influenced by a
variety of effectors, with glucose being the primary and most
important stimulus. Insulin secretion requires metabolism of
glucose in the ␤-cell with an associated increase in total
intracellular ATP and an increase in the cytosolic ATP/ADP
ratio (7, 18, 36). Increases in the cytosolic ATP concentration
result in the sequential closure of KATP channels, depolarization of the plasma membrane, opening of voltage-sensitive
L-type Ca2⫹ channels, Ca2⫹ influx, and insulin secretion (15,
34). The uptake of glucose and its phosphorylation to glucose
6-phosphate are catalyzed by high Km glucose transporter 2
and the rate-limiting high Km glucokinase, respectively. These
“glucosensors” ensure an increase in glucose phosphorylation,
since blood glucose concentrations rise after a carbohydrate-
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rich meal. Pyruvate derived from glucose is channeled predominantly into its mitochondrial metabolism because of low levels
of lactate dehydrogenase activity and of the monocarboxylate
transporter-1 for lactate in the plasma membrane of islets (23,
24, 26, 34). Another link between the cytosolic and mitochondrial metabolism of glucose is the transfer of NADH via the
glycerol 3-phosphate shuttle and the malate-aspartate shuttle
for ATP production (8, 22).
Evidence shows that metabolites derived from mitochondrial metabolism of pyruvate generated primarily from glucose
and to a limited extent from other nutrients (such as amino
acids) play a critical role in metabolism-secretion coupling of
insulin secretion by ␤-cells (24, 26). Pyruvate is converted to
acetyl-CoA and oxaloacetate by the action of the pyruvate
dehydrogenase complex (PDC) and pyruvate carboxylase
(PC), respectively. Approximately 50% of glucose-derived
pyruvate is converted to acetyl-CoA by PDC, and the remainder of the pyruvate flux is mediated by PC for anaplerosis to
generate the tricarboxylic acid (TCA) cycle intermediates for
“pyruvate cycling” in ␤-cells (24, 26). Hence, PDC plays a
decisive role in the generation of ATP and several coupling
factors generated in the mitochondria (e.g., GTP, glutamate,
etc.) and in the cytosol (e.g., malonyl-CoA, NADPH, etc.)
using the mitochondria-derived compounds for enhancing insulin secretion by ␤-cells. The roles of PC (12, 42) as well as
several key enzymes such as malic enzyme (10, 29), ATPcitrate lyase (10), acetyl-CoA carboxylase (33), and cytosolicNADP-isocitrate dehydrogenase (31) in glucose-stimulated insulin secretion (GSIS) have been investigated extensively using isolated islets and cultured ␤-cell clonal lines. However,
several of these observations have been contradicted for pyruvate carboxylase (14), cytosolic malic enzyme (1, 32), and
ATP-citrate lyase (25). It should be emphasized that these
investigations were performed using clonal ␤-cells or cultured
islets treated by transient siRNA transfection or stable shRNA
plasmids. Surprisingly, there are no investigations on PC or
other key enzymes involved in pyruvate cycling in ␤-cells in
vivo using gene knockout technology. Although ⬃50% of the
pyruvate derived from glucose is decarboxylated to acetyl-CoA
by the PDC reaction, the role of PDC in GSIS has not been
investigated extensively.
Mammalian PDC is composed of multiple copies of three
catalytic components, one binding protein, and dedicated kinases and phosphatases (28). PDC activity is intricately regulated by phosphorylation (inactivation)/dephosphorylation (activation) of pyruvate dehydrogenase (PDH) (␣2␤2 heterotetramer) component by dedicated families of PDH kinases
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(PDK1-4) and PDH phosphatases (PDP1–2) (11, 28, 39). In
mammals, PDH␣ is encoded by two genes, an X-linked allele
(Pdha1 in mouse) that is expressed in somatic cells and an
autosomal, intronless paralogue (Pdha2 in mouse) that is
expressed only in postmeiotic spermatogenic cells (2, 6).
Using several experimental approaches, such as expression
of PDC regulatory enzymes (PDK and PDP) (27), the use of
dichloroacetate as PDK inhibitor (27), reduction in PDC activity using a PDH-specific siRNA approach (42), and measurements of pyruvate-carbon flux via PDC using isotopomer
analysis (3, 20), it has been reported that PDC played no role
or only a minor regulatory role in GSIS by cultured clonal
␤-cells and isolated islets. These analyses relied upon either
indirect measurements or in vitro activity measurements. The
findings of these studies remain controversial. No studies are
reported using stably modified cell preparations or in vivo
alterations in PDC activity. The approach employed in one
study (27) was overexpression of a specific PDH kinase or
phosphatase to regulate phosphorylation or dephosphorylation
status of PDC and not to suppress or delete expression of one
of the genes involved in the catalytic components of PDC. We
have developed a murine model that carries a mutation in the
X-linked Pdha1 gene encoding the subunit of the PDH component of PDC (16). Availability of a murine model with
targeted Pdha1 mutation has allowed us to investigate the
consequences of an isolated ␤-cell-specific PDC deficiency on
insulin secretion in male mice. The findings presented here
show that chronic PDC deficiency in ␤-cells impairs GSIS both
in vivo and in vitro.
MATERIALS AND METHODS

Generation of pancreatic ␤-cell-specific PDH-deficient male mice.
All animal experiments were conducted in accordance with the Guide
for the Use and Care of Laboratory Animals and approved by the
Institutional Animal Care and Use Committee of the State University
of New York at Buffalo. A strategy using the Cre-loxP system was
employed to introduce a silent mutation in the Pdha1 gene (2 loxP
sites introduced into intronic sequences flanking exon 8) that could
then be induced in vivo to produce a null mutation (16). To generate
a ␤-cell-specific deletion of the Pdha1 gene, females (genotype
Pdha1flox8/Pdha1flox8) were bred with transgenic male mice harboring
a Cre recombinase transgene driven by the rat insulin gene II promoter (The Jackson Laboratory, Bar Harbor, ME). Previous studies
have shown that Cre recombinase is expressed strongly in pancreatic
␤-cells and weakly in certain brain regions (certain neurons of the
hypothalamus) of these transgenic Cre mice, and its expression was
readily detected in these cells at 11.5 days postcoitus (5, 9).
The progeny were tested for the presence or absence of the Cre
transgene by polymerase chain reaction (PCR) analysis using tail
DNA samples on postnatal day 15, except for 1-day-old neonates (16,
37). Genotyping of the progeny identified the presence of the Cre
transgene in both sexes. To generate control male mice (␤-PDHCT),
females (genotype: Pdha1flox8/Pdha1flox8) were bred with wild-type
males (genotype: Pdha1wt/Y). Newborns were reared by their dams
and weaned on postnatal day 21 onto a rodent laboratory chow
(%calorie distribution: 70 carbohydrate, 10.9 fat, and 19.1 protein)
and water ad libitum and remained on this regimen until they were
euthanized. The tissue-specific genotype was determined by PCR
analysis (37) using tissue DNA samples. Genomic DNA was isolated
with Omni Prep kit (Bio-WORLD, Dublin, OH) from isolated islets,
liver, and skeletal muscle. The presence of Pdha1 alleles (Pdha1wt,
Pdha1flox8, and Pdha1⌬ex8) and Cre transgene was determined by
PCR analysis (37) using the specific sets of primers (Pdha1 sense
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primer 5=-AGCAGCCAGCA CGGACTACT-3=, antisense primer 5=GCAGCCAAACAGATTACACC-3=, and Cre primers sense 5=GCATTTCTGGGGATTGCTTA-3= and antisense 5=-CCCGGCAA
AACAGGTAGTTA-3=), as described previously (37).
Insulin measurements. Trunk blood was collected and centrifuged
and the serum stored at ⫺20°C until being assayed for insulin using
a commercially available radioimmunoassay kit (Millipore, Billerica,
MA). To measure pancreatic insulin content, weighed pieces of
pancreata were homogenized by sonication in acid-ethanol solution
(38) and centrifuged, and the supernatants stored at ⫺20°C until they
were assayed for insulin. For 1-day-old mice, the whole pancreas from
each male mouse (sex based on genotype) was treated as indicated
above, and the insulin content was expressed as the quantity of insulin
per pancreas.
Isolation of islets and GSIS studies. Islets were isolated by collagenase digestion (41). Briefly, the carefully trimmed pancreas was
minced and digested with collagenase (Crescent Chemical, Islandia,
NY), and the islets were picked manually under a stereomicroscope.
Five islets per tube were preincubated for 30 min in 250 l of
Krebs-Ringer bicarbonate (KRB) buffer containing 16 mM HEPES,
5.5 mM glucose, and 0.01% bovine serum albumin, pH 7.4, at 37°C
under an atmosphere of 95% O2-5% CO2 in a shaking water bath. The
islets were resuspended in fresh KRB buffer containing 5.5 mM
glucose with or without added 11.2 mM glucose (16.7 mM final), 10
mM ␣-ketoisocaproate, or 25 mM KCl, and an aliquot was withdrawn
at 60 min for determination of secreted insulin (38).
PDC activity determination. Isolated islets were homogenized in 50
mM MOPS buffer, pH 7.4, 80 mM KCl, 2 mM MgCl2, 0.5 mM
EDTA, 0.5 mM phenylmethylsulfonyl fluoride, and 0.1 g/ml leupeptin, freeze-thawed in liquid nitrogen three times, and centrifuged at
600 g for 10 min. To measure total PDC activity, the supernatant was
dephosphorylated (to completely activate PDC) with purified recombinant rat PDH phosphatase 1 (37). Total PDC activity was determined by production of 14CO2 from [1-14C]pyruvic acid (GE Healthcare, Piscataway, NJ) (19).
␤-Cell morphometric analysis. Morphometric analysis of pancreata
from 33- and 108-day-old ␤-PDHCT and ␤-cell-specific PDH-deficient (␤-PDHKO) male mice was performed using a Carl Zeiss
transmitted light microscope at a magnification of ⫻250 or ⫻400.
Pancreata were fixed in 10% formalin and embedded in paraffin using
a standardized protocol, and sections of 5 m were cut and mounted
on Superfrost-plus slides (Fisher Scientific, Toronto, ON, Canada).
Immunohistochemistry was performed to localize insulin using a
modified avidin-biotin peroxidase method, as described previously
(40). Tissue sections were counterstained with Carrazi’s hematoxylin
and mounted under glass coverslips with Eukit (Ruth Wagener Enterprises, Newmarket, ON, Canada). Automatic image analysis of the
pancreatic sections for calculation of tissue areas was performed with
Northern Eclipse, version 6.0, morphometric analysis software (Empix Imaging, Mississauga, ON, Canada). The number and average
area of small (⬍5,000 m2), medium, and large (⬎10,000 m2) islets
was calculated for each group from five sections per pancreas taken at
50 – 60 section intervals to represent the head region of the pancreas.
The minimum size for an islet was taken to be a cluster of three or
more insulin-positive cells. The mean area of individual ␤-cells was
also measured from insulin-immunoreactive cells. Approximately 100
cells were selected from at least five islets within each pancreas.
Glucose tolerance test. Intraperitoneal glucose tolerance test was
performed on nonanesthetized, overnight-fasted mice receiving a
glucose dose of 1.5 mg/g body wt (37). Tail blood glucose levels were
measured using a glucometer (Ascencia Elite; Bayer, Mishiwaka, IN)
before (0 min) and 15, 30, 45, 60, 90, and 120 min after an
intraperitoneal injection of glucose.
In vivo insulin secretion using hyperglycemic clamp. These experiments were conducted following the standardized procedures established at the Yale Mouse Metabolic Phenotyping Center and approved
by the Institutional Animal Care and Use Committee of Yale Univer-
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sity (43). The procedure involved chronic cannulation of the right
jugular vein to establish a chronic catheter ⬃7 days earlier for
intravenous infusion of glucose during the clamp. On the day of the
clamp experiment, an overnight-fasted mouse was placed in a restrainer for the experiment to be conducted in an awake and minimally
stressed state. The tail was tethered using tape for 2 h prior to the start
of experiment for acclimatization. The blood samples were obtained
from the tail vessels requiring a small tail cut. To assess in vivo insulin
secretion, a 90-min hyperglycemic clamp was conducted with a
primed and variable infusion of 20% glucose to raise and maintain
plasma glucose concentrations at ⬃25 mM. Blood samples (20 l)
were collected at 5- to 10-min intervals during the acute phase and a
15-min interval during the late phase for the measurement of plasma
glucose and insulin concentrations. Plasma glucose concentration was
measured immediately using a Beckman Glucose Analyzer II (Beckman, Fullerton, CA), and plasma insulin levels were assessed by
radioimmunoassay using a kit from Linco Research (St. Charles,
MO). The area under the curve of plasma insulin profiles was assessed
to determine glucose-induced insulin secretion in vivo (i.e., pancreatic
␤-cell function). Acute and late insulin responses were defined as area
under curve of 0- to 30- and 30- to 90-min insulin profiles, respectively.
Statistics. The results are expressed as means ⫾ SE of the number
of independent observations as indicated. The significance of the
difference between the two groups was determined by Student’s t-test,
and a P value of ⬍0.05 was considered significant.
RESULTS

Generation of ␤-PDHKO male mice. ␤-Cell-specific PDC
deficiency in mice was induced by breeding homozygous
female mice (genotype: Pdha1flox8/Pdha1flox8) carrying the
targetable mutation with transgenic homozygous male mice
harboring a Cre recombinase transgene driven by the rat
insulin gene II promoter (genotype: Pdha1wt/Y; Crebetacell). No
embryonic lethality was observed for male and female
progeny of this mating because the average litter size was
comparable with the litter size of mating of floxed females
(genotype: Pdha1flox8/Pdha1flox8) with wild-type males (genotype: Pdha1wt/Y). PCR analysis of DNA prepared from islets
isolated from ␤-PDHKO male mice (age 12 wk) showed the
presence of the deleted Pdha1 gene (Pdha1⌬ex8, 400 bp) and
the Pdha1flox8 (800-bp fragment) (Fig. 1, A and B, lanes 3– 6)
and the Cre transgene (168-bp fragment; results not shown) in
the ␤-PDHKO islets. In addition to ␤-cells, islets also contained ␣-, ␥-, and ␦-cells that did not express the Cre gene in
␤-PDHKO mice. However, the functional Pdha1flox8 gene was
present in the latter cell types, resulting in the detection of the
800-bp fragment in DNA isolated from islets from ␤-PDHKO
male mice (Fig. 1B, lanes 3– 6). On the other hand, only the
Pdha1flox8 (800-bp fragment) was observed in islets from
control (␤-PDHCT) male mice (Fig. 1B, lanes 1 and 2). DNA
prepared from liver and skeletal muscle samples from
␤-PDHKO male mice showed only the presence of Pdha1flox8
allele (800 bp), indicating the absence of Cre expression in
these tissues (Fig. 1B, lanes 7 and 8).
To decipher whether a deficiency of PDC activity in ␤-cells
affected body weight gains in ␤-PDHKO male mice, body
weights of mice in the postweaning period were determined.
Although the body weights of ␤-PDHKO male mice were
significantly lower on postnatal day 30 compared with agematched control ␤-PDHCT male mice (15.0 ⫾ 0.7 vs. 18.7 ⫾
0.7 g, respectively), this difference in body weight was not

Fig. 1. A schematic representation of 3 partial Pdha1 alleles (A) and PCR
analysis (B) of tissue DNA preparations of 4-mo-old ␤-PDHCT control (CT)
and ␤-cell-specific PDH-deficient (␤-KO) male progeny. In A, the presence of
the inserted loxP sequence is indicated by a solid vertical bar in introns. The
locations and direction of sense and antisense primers are depicted by arrows.
The expected sizes of PCR products are also listed. The results in B show the
presence of Pdha1flox8 allele (800 bp) and Pdha1⌬ex8 allele (400 bp). As
expected, islets isolated from 2 CT mice (lanes 1 and 2) had only the flox
allele, whereas islets isolated from 4 different ␤-KO mice (lanes 3– 6) showed
the presence of both the Pdha1flox8 and Pdha1⌬ex8 alleles, indicating deletion
in ␤-cells. Liver and skeletal muscle taken from a ␤-KO mouse (reported in
lane 3) had only the flox allele (lanes 7 and 8). M denotes a DNA ladder
marker lane.

detected between the two groups by age 4 mo [␤-PDHCT: 30.7 ⫾
1.3 g (n ⫽ 8); ␤-PDHKO: 30.7 ⫾ 1.1 g (n ⫽ 13)].
To demonstrate that the targeted deletion in the Pdha1 gene
in islets of ␤-PDHKO male mice resulted in a corresponding
reduction in its enzyme activity, PDC activity was determined
in islets isolated from 3-mo-old male mice. Total PDC activity
was markedly decreased (⬃50%) in islets from ␤-PDHKO
male mice compared with the age-matched ␤-PDHCT male
mice (Fig. 2). One of the reasons for remaining residual PDC
activity in islets of ␤-PDHKO male mice is the activity derived
from other cell types constituting an islet. Such a possibility is
indicated by the presence of the 800-bp fragment (Fig. 1B)
corresponding to the wild-type Pdha1 gene allele in islets of
the ␤-PDHKO male mice. It is also plausible that Pdha1 gene
deletion did not occur in all of the ␤-cells.
Development of hyperglycemia in ␤-PDHKO male mice. To
determine the effect of PDC deficiency in ␤-cells on plasma
glucose levels in the ␤-PDHKO mice during postnatal life, tail
blood glucose levels were determined in randomly fed mice at
various ages. During the suckling period (from postnatal days
15–25), blood glucose levels were increased significantly in
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Fig. 2. “Total” pyruvate dehydrogenase complex (PDC) activity in islets from
␤-KO and CT mice at 4 mo of age. Results are means ⫾ SE (n ⫽ 4). *P ⬍
0.05.

␤-PDHKO male mice (⬃1.5- to 2-fold) compared with the
levels in age-matched ␤-PDHCT male mice (Fig. 3A). As
expected based on random inactivation of one of the two X
alleles in heterozygous progeny females (maternally derived
Pdha1flox8 allele and paternally derived Pdha1wt allele), there
were no significant differences in blood glucose levels in
age-matched ␤-PDHKO female mice compared with corresponding wild-type female mice during the suckling period
(Fig. 3B). Due to heterozygous genotype, ␤-PDHKO female
mice were not investigated further in this study. In the postweaning period up to postnatal day 90, blood glucose levels
were significantly higher in ␤-PDHKO male mice compared
with age-matched ␤-PDHCT male mice; however, this significant difference in blood glucose levels was not maintained in
older ␤-PDHKO male mice (Fig. 3C).
Altered pancreatic and plasma insulin levels in ␤-PDHKO
male mice. To determine whether a deficiency of PDC activity
in pancreatic islets in ␤-PDHKO male mice affected levels of
insulin in these mice, plasma insulin levels in ␤-PDHKO male
mice and age-matched ␤-PDHCT males were measured in the
postweaning period. Plasma insulin levels were reduced significantly (⬃45%) in ␤-PDHKO male mice on postnatal days
28, 56, and 84 (Fig. 3D). Interestingly, there was a significant
increase in plasma insulin levels of 84-day-old ␤-PDHKO
mice compared with that of 56-day-old ␤-PDHKO mice (Fig.
3D). This may explain in part the observed near-normalization of blood glucose levels in these mice after 90 days of
age (Fig. 3C).
Pancreatic insulin content was also markedly reduced in
␤-PDHKO male mice on the postnatal days 14, 28, and 70
(Fig. 4A). Of particular interest is the observation that even on
postnatal day 1 (within 24 h after birth) pancreatic insulin
content in newborn male pups was significantly reduced (Fig.
4B), and this defect persisted up to postnatal age 70 days (the
last time point investigated). The observation that the insulin
secretion response of islets from 70-day-old ␤-PDHKO adult
male mice to a glucose stimulus (at both 5.5 and 16.7 mM) was
markedly reduced at 60 min indicated that ␤-cell-specific PDH
deletion impacted the functional capacity of islets from the
␤-PDHKO male mice (Fig. 5). The insulin secretion response
by islets from ␤-PDHKO male mice to 25 mM KCl was not
significantly different from that of ␤-PDHCT, indicating a
pre-KATP channel defect despite decreased insulin content (Fig.
5). The insulin secretion by islets from ␤-PDHKO mice to 10
mM ␣-ketoisocaproate (KIC) plus 5.5 mM glucose was lower
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compared with that by islets from ␤-PDHCT mice. Although
the catabolism of KIC in the mitochondria generates acetylCoA, the lack of acetyl-CoA production from glucose-derived
pyruvate by islets from ␤-PDHKO mice might account for a
lesser than normal response (Fig. 5).
Islet morphometric analysis. When islet morphometric analysis was performed, no change was seen in the number of
different sizes of islets [average islet area (m2): 1,604 ⫾ 135
and 1,533 ⫾ 224 for small-, 6,838 ⫾ 268 and 6,966 ⫾ 485 for
medium-, and 24,867 ⫾ 4,897 and 31,313 ⫾ 5,352 for largesized islets for ␤-PDHCT and ␤-PDHKO male mice, respectively] in ␤-PDHKO mice compared with controls at postnatal
age 33 days and also at 108 days (results not shown). However,
there was a significant increase in the mean size of individual
␤-cells in islets from 33-day-old ␤-PDHKO compared with
␤-PDHCT male mice (average ␤-cell size: 191 ⫾ 8.4 m2 for
␤-PDHCT and 228 ⫾ 10.8 m2 for ␤-PDHKO, P ⬍ 0.05). In
contrast, no difference was seen in the mean size of individual
␤-cells between ␤-PDHKO (223 ⫾ 4 m2) and ␤-PDHCT
(223 ⫾ 17 m2) animals at 108 days, suggesting a possibility
of glycemic stress effect on ␤-cell hypertrophy.
In vivo studies. Glucose tolerance test was performed on
␤-PDHCT (control) and ␤-PDHKO male mice at age 8 wk by
intraperitoneal glucose injection (1.5 g/kg body wt) after an
overnight fast. The fasting blood glucose levels (time 0) between the two groups were not significantly different (Fig. 6).
Compared with the response of blood glucose levels of
␤-PDHCT male mice over a 120-min period, the response of
8-wk-old ␤-PDHKO male mice was abnormal with significant
levels of hyperglycemia over the same period (Fig. 6).
To confirm that the insulin secretion function was impaired
in vivo, hyperglycemic clamp studies were conducted in
␤-PDHKO and ␤-PDHCT male mice at 4 mo of age after an
overnight fast (Fig. 7). The blood glucose was rapidly increased and maintained at ⬃25 mM throughout the clamp (Fig.
7A). Analysis of plasma insulin levels at multiple time points
during the clamp period clearly indicated significant impairment of the insulin secretion response in vivo of ␤-PDHKO
mice manifested by a significant decrease in the area under the
curve for insulin secretion during both acute (0 –30 min) and
late phases (30 –120 min) compared with ␤-PDHCT mice (Fig.
7, B and C).
DISCUSSION

The generation of ATP from acetyl-CoA oxidation due to
the metabolism of pyruvate in the mitochondria of ␤-cells
together with the secondary signals generated from the TCA
cycle intermediates plays a critical role in the coupling of
glucose metabolism with insulin secretion (15, 24, 26). Pyruvate is nearly equally metabolized by PDC and PC in the
mitochondria, and pyruvate cycling in ␤-cells has been shown
to involve three different cycles (namely the pyruvate-malate,
pyruvate-citrate, and pyruvate-isocitrate cycles). The roles of
PC and other key enzymes involved in these cycles have been
investigated extensively for GSIS using isolated islets and
cultured clonal ␤-cell lines (10, 12, 14, 17, 29, 31–33, 42). The
results presented here show in vivo and in vitro evidence for a
key role played by PDC in insulin secretion in ␤-cells because
of its central role in the production of cellular ATP and the
participation in the operation of the three pyruvate cycling
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pathways. Furthermore, our ␤-PDHKO mouse model represents the first mouse model in which a mitochondrial oxidative
enzyme involved in glucose oxidation has been deleted to
investigate insulin secretion by ␤-cells.

Fig. 4. Effects of pyruvate dehydrogenase (PDH) deletion on pancreatic insulin
content in 14-, 28-, and 70-day-old (A) and 1-day-old (B) CT and ␤-KO male
mice. Results are means ⫾ SE [n as indicated: 1 (n ⫽ 10), 14 (n ⫽ 10), 28 (n ⫽
5), and 70 days (n ⫽ 4)]. *P ⬍ 0.05.

GSIS by ␤-cells requires glucose metabolism to increase
intracellular ATP content and also generation of coupling
factors (such as malonyl-CoA, NADPH, GTP, ␣-ketoglutarate,
etc.) (15, 24, 26). The pathways involved in meeting these
requirements in ␤-cells obligate that a sizeable amount of
pyruvate formed from glucose metabolism via glycolysis is
further metabolized via PDC in the mitochondria. The importance of this requirement for insulin secretion is clearly evident
from the results presented in this study. A deletion of the
Pdha1 gene in ␤-cells resulted only in a reduction in PDH (and
hence, PDC) activity in islets from ␤-PDHKO male mice, with
a significant impairment in GSIS in both in vitro and in vivo
conditions. It is possible that some acetyl-CoA can be generated from endogenous substrates such as fatty acids and some
amino acids. However, these endogenous substrates were not
sufficient to compensate for the loss of acetyl-CoA generated
by PDC in vivo due to its deficiency. The oxidation of acetylCoA derived from pyruvate in the TCA cycle coupled with the
respiration/oxidative phosphorylation processes results in the
generation of ATP. This process is likely to be reduced in
␤-cells from ␤-PDHKO male mice. Additionally, the formation of the TCA cycle intermediates in the mitochondria
(anaplerosis) and their metabolism in the cytosol via three

Fig. 3. A and B: tail blood glucose levels in randomly fed male and female
mice, respectively, during the first 25 postnatal days. C: tail blood glucose
levels in randomly fed male mice from postnatal day 15 to 150. D: plasma
insulin levels in 28-, 56-, and 84 day-old ␤-KO and CT male mice. Open bars
and Œ, CT mice; filled bars and , ␤-KO mice. Results are means ⫾ SE (n ⫽
6 –9 for blood glucose and 5– 6 for plasma insulin levels). *P ⬍ 0.05 for
comparison between age-matched CT and ␤-KO mice; #P ⬍ 0.05 for comparison of plasma insulin levels between ␤-KO mice at age 56 and 84 postnatal
days.
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Fig. 5. Effects of PDH deletion on insulin secretion. Glucose-stimulated insulin
secretion in the presence of 5.5 or 16.7 mM glucose (G), 5.5 mM G ⫹ 25 mM
KCl, and 5.5 mM G ⫹ 10 mM ␣-ketoisocaproate for 60 min by islets isolated
from pancreata of 10-wk-old CT and ␤-KO male mice. Results are means ⫾
SE (n ⫽ 8 –10). *P ⬍ 0.05.

different cycles (cataplerosis) result in the formation of several
coupling factors required for insulin secretion. Interestingly,
these processes depend, in part, on the initial action of PDC in
the mitochondria.
Pancreatic ␤-cells possess a high level of PC (35). A large
body of evidence indicates that PC plays an important role for
the synthesis of the TCA cycle intermediates, which are involved in the transport of the reducing equivalents and acetyl
groups out of mitochondria to generate NADPH and acetylCoA via cataplerosis in the cytosol (15, 24, 26). The pyruvatemalate cycle involving PC in the mitochondria and malic
enzyme in the cytosol regenerates pyruvate, producing
NADPH in the cytosol. This cycle does not require the participation of acetyl-CoA carbons directly in this pathway. However, acetyl-CoA acts as an allosteric activator of PC and
hence, regulates the carbon flux via PC.
The formation of citrate, isocitrate, and ␣-ketoglutarate in
the mitochondria requires both acetyl-CoA and oxaloacetate
from pyruvate via the actions of PDC and PC, respectively.
The transport of citrate from the mitochondria to the cytosol
and its metabolism in the cytosol via the pyruvate-citrate
shuttle generate both NADPH and acetyl-CoA, which is converted to malonyl-CoA, as metabolic coupling factors. Cytosolic malonyl-CoA acting as a coupling factor inhibits carnitine
palmitoyl-CoA transferase I, resulting in an increase in cyto-

Fig. 6. Intraperitoneal glucose tolerance test in 8-wk-old ␤-KO and CT male
mice. The results are means ⫾ SE (n ⫽ 4 or 5). *P ⬍ 0.05.

Fig. 7. Hyperglycemic clamp analysis in ␤-KO and CT mice at the age of 16
wk. A: A 90-min clamp was conducted with a primed and variable infusion of
glucose to raise and maintain plasma glucose concentrations at ⬃25 mM in
␤-KO (n ⫽ 13) and CT (n ⫽ 8) mice. B: plasma insulin was measured at the
indicated time points. C: values indicate the area under the curve (AUC) for
insulin secretion throughout the experiment (0 –90 min) or during acute (0 –30
min) and late (30 –90 min) phases of secretion. *P ⬍ 0.05, using unpaired
2-tailed t-test in B.

solic long-chain acyl-CoA (30). A glucose-induced increase in
cytosolic malonyl-CoA concentration requires first the action
of PDC to generate acetyl-CoA from pyruvate in the mitochondria and subsequently its transport as citrate to regenerate
acetyl-CoA for the synthesis of malonyl-CoA in the cytosol.
Thus, the role of PDC is central for the formation of acetylCoA from glucose-derived pyruvate in the mitochondria.
The pyruvate-isocitrate cycle can generate NADPH in the
cytosol via NADP-isocitrate dehydrogenase. For this shuttle
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to operate, the formation of acetyl-CoA from pyruvate by
PDC is critical for the formation of citrate and then isocitrate. It is interesting to note that since the cytosolic malic
enzyme is lacking in mouse islets (21), pyruvate cycling via
the pyruvate-isocitrate cycle may play an even greater role
for NADPH generation in mouse islets.
In ␤-PDHKO male mice, there was no effect on the distribution of the number of different sizes of islets, but rather,
there was an increase in ␤-cell size in islets on postnatal day 33
but not on postnatal day 108. We speculate that increased
␤-cell size may be a compensatory response to chronic hyperglycemia observed in younger ␤-PDHKO mice (Fig. 3C). It is
likely that the oxidation in ␤-cells of ␤-PDHKO male mice of
fatty acids derived from milk fat as well as the increased
availability of ketone bodies (4, 13) can provide energy for the
ontogeny of islets during the suckling period but will not
support preproinsulin gene expression and insulin secretion by
␤-cells.
In summary, our study is the first to employ a gene knockout
approach to PDC, the key enzyme involved in regulating
pyruvate oxidation and TCA cycle flux for GSIS in ␤-cells.
Acetyl-CoA derived from pyruvate oxidation via PDC is important in the functioning of the three pyruvate cycling pathways for the production of the coupling factors involved in
insulin secretion by ␤-cells. Studies so far reported for GSIS
involving key enzymes for pyruvate cycling are performed
using transiently or stably transfected clonal ␤-cells or cultured
islets only, and the findings often contradict the putative roles
of several key enzymes in GSIS. Limitations of these approaches have recently been pointed out by Brown et al. (1).
The results presented here from both in vitro and in vivo
studies demonstrate the central role played by PDC in GSIS by
␤-cells.
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